Rallying the Healthcare Industry Around Precision Medicine, Confronting Challenges

Pharmacogenomics and precision medicine are evolving fields that are full of opportunities for advancement and improving patient outcomes, but seizing these opportunities may require a concerted effort from healthcare stakeholders. Cynthia Yu, PharmD, director of precision medicine at The Profero Team, and Scott Betzelos, MD, chief medical officer and vice president of HMO strategy and affordability at Blue Care Network, offer their perspectives on the challenges and opportunities of precision medicine and pharmacogenomics and its future.